CLOs on the Move

Accelerate Diagnostics

www.acceleratediagnostics.com

 
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The companys revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the Accelerate ID/AST System development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Michael Bridge
General Counsel Profile

Similar Companies

Anthogyr

Anthogyr is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

iCAD

With iCAD`s technology, cancer has finally met its match. As a global medical technology leader providing innovative cancer detection and therapy solutions, our technologies empower clinicians worldwide with an arsenal of tools to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before. The ProFound AI Breast Health Suite is the first, best, and only complete, triple-threat solution that combines cancer detection, density assessment, and risk evaluation – all designed to accelerate discovery and improve outcomes. Our leading-edge cancer detection solution, ProFound AI®, is clinically proven to find cancers earlier and with greater accuracy, while slashing reading time for radiologists by more than half. PowerLook® Density Assessment simplifies and standardizes breast density reporting and stratification, offering consistent, accurate and reliable breast density categorization. And the latest addition to our Breast AI Suite, ProFound AI® Risk, is the world`s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram. Our Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is transforming the cancer treatment experience by empowering physicians to precisely and effectively target tumors anywhere in the body, anywhere in the world. Using the world`s smallest X-ray source, clinicians can precisely destroy disease while preserving healthy tissue, leaving cancer nowhere to hide.

Cadent

Cadent is a Carlstadt, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Torax Medical

Torax Medical`s core technology applies the unique properties of specialized magnets to precisely restore the barrier function of sphincters. Our technology platform, Magnetic Sphincter Augmentation, uses the attraction forces to augment weak or defective sphincter muscles to treat Gastroesophageal Reflux Disease (GERD) and Accidental Bowel Leakage (fecal or bowel incontinence).

Barlow Respiratory Hospital

Barlow Respiratory Hospital is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.